{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-000395","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.661996+00:00","generated_at":"2026-05-15T18:45:14.191661+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Artelo Biosciences effects 1-for-3 reverse stock split effective March 10, 2026","bullets":["Reverse split ratio 1-for-3; outstanding shares reduced from 2,124,772 to ~708,258.","Effective at market open on March 10, 2026; new CUSIP 04301G706.","No fractional shares issued; holders otherwise entitled to fractional share receive one whole share.","All outstanding warrants and other derivatives adjust automatically per their terms.","Board approved without stockholder vote under Nevada Revised Statutes 78.207."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-000395","json":"https://secwatch.observer/filing/0001640334-26-000395.json","markdown":"https://secwatch.observer/filing/0001640334-26-000395.md","text":"https://secwatch.observer/filing/0001640334-26-000395.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:45:14.191661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d7e9c7dc427ddbf42e8654e8a4ddc869baced91e","claim":"ARTELO BIOSCIENCES, INC.: Effected a one-for-three reverse stock split of common stock and reduced authorized shares accordingly (effective 2026-03-10).","evidence_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-211978","ticker":"JPM","company_name":"JPMORGAN CHASE & CO","filed_at":"2026-05-07T23:59:59+00:00","headline":"JPMorgan issues $3B of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-211978","json":"https://secwatch.observer/filing/0001193125-26-211978.json","markdown":"https://secwatch.observer/filing/0001193125-26-211978.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/0001193125-26-211978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/d903351d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/19617/000119312526211978/0001193125-26-211978-index.htm"}},{"accession":"0001829126-26-004744","ticker":"KALA","company_name":"KALA BIO, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004744","json":"https://secwatch.observer/filing/0001829126-26-004744.json","markdown":"https://secwatch.observer/filing/0001829126-26-004744.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/kalabio_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"On May 7, 2026, KALA BIO, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-50 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on May 8, 2026 (the “ Reverse Stock Split ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm"}},{"accession":"0001437749-26-013905","ticker":"BKYI","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2026-04-29T23:59:59+00:00","headline":"BIO-key announces 1-for-10 reverse stock split to regain Nasdaq compliance","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013905","json":"https://secwatch.observer/filing/0001437749-26-013905.json","markdown":"https://secwatch.observer/filing/0001437749-26-013905.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/0001437749-26-013905-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/bkyi20260429_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"the Company filed a Certificate of Amendment (the “ Certificate of Amendment ”) with the Secretary of State of the State of Delaware to effect the reverse stock split. The Certificate of Amendment will become effective at 5:00 p.m., Eastern Time, on April 29, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926013905/0001437749-26-013905-index.htm"}},{"accession":"0001628280-26-039465","ticker":"IOT","company_name":"Samsara Inc.","filed_at":"2026-06-01T20:07:41+00:00","headline":"Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039465","json":"https://secwatch.observer/filing/0001628280-26-039465.json","markdown":"https://secwatch.observer/filing/0001628280-26-039465.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/iot-20260601.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm"}},{"accession":"0001193125-26-215756","ticker":"GIG","company_name":"GigCapital7 Corp.","filed_at":"2026-05-11T23:59:59+00:00","headline":"GigCapital7 domestication from Cayman Islands to Delaware effective May 8 after shareholder vote","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-215756","json":"https://secwatch.observer/filing/0001193125-26-215756.json","markdown":"https://secwatch.observer/filing/0001193125-26-215756.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023730/000119312526215756/0001193125-26-215756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023730/000119312526215756/d72988d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"On May 8, 2026, GigCapital7 effectuated the Domestication by filing (i) a voluntary declaration pursuant to Section 206(3) of the Companies Act (revised) of the Acts of the Cayman Islands, (ii) a certificate of corporate domestication with the Secretary of State of the State of Delaware (the “ DE SoS ”), and (iii) an interim certificate of incorporation with the DE SoS (the “ Domesticated GigCapital7 Charter ”). Domesticated GigCapital7 also adopted bylaws (the “ Domesticated GigCapital7 Bylaws ” and together with the Domesticated GigCapital7 Charter, the “ Domesticated GigCapital7 Governing Documents ”) in connection with the Domestication.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2023730/000119312526215756/0001193125-26-215756-index.htm"}},{"accession":"0001193125-26-214945","ticker":"MAN","company_name":"ManpowerGroup Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"ManpowerGroup declares $0.72 dividend; shareholders approve equity plan amendment and director removal without cause","event_type":"other_material","sec_items":["5.02","5.03","5.07","8.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-214945","json":"https://secwatch.observer/filing/0001193125-26-214945.json","markdown":"https://secwatch.observer/filing/0001193125-26-214945.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/0001193125-26-214945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/man-20260508.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"the Board of Directors of the Company amended Section 3.3 of Article III of the Company’s Amended and Restated By-Laws (the “ By-Laws Amendment ”) to permit the removal of a director with or without cause by the affirmative vote of two-thirds of the outstanding shares of capital stock of the Company entitled to vote at a meeting of shareholders duly called for such purpose. The effective date of the By-Laws Amendment is May 8, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/871763/000119312526214945/0001193125-26-214945-index.htm"}},{"accession":"0002045458-26-000015","ticker":null,"company_name":"Stonepeak-Plus Infrastructure Fund LP","filed_at":"2026-05-05T23:59:59+00:00","headline":"Stonepeak-Plus Infrastructure Fund sells $65M in units, declares March distributions","event_type":"other_material","sec_items":["1.01","3.02","8.01","5.03","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0002045458-26-000015","json":"https://secwatch.observer/filing/0002045458-26-000015.json","markdown":"https://secwatch.observer/filing/0002045458-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2045458/000204545826000015/0002045458-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2045458/000204545826000015/sp-20260429.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"On May 4, 2026, Stonepeak-Plus Infrastructure Fund Associates LP, the general partner of the Fund (the “General Partner”), entered into the Third Amended and Restated Limited Partnership Agreement of the Fund (the “Amended Partnership Agreement”), to (i) authorize the General Partner to cause the Fund to issue Units designated as Class Z - Series D-2 Units, Class Z - Series I-2 Units and Class Z - Series S-2 Units, and cancel Class D-2 Units, Class I-2 Units and Class S-2 Units, each of which have not been issued, and (ii) make certain related changes and incorporate other administrative updates.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2045458/000204545826000015/0002045458-26-000015-index.htm"}},{"accession":"0001104659-26-053558","ticker":null,"company_name":"Clearway Energy LLC","filed_at":"2026-05-01T23:59:59+00:00","headline":"Clearway Energy LLC converts Class A units to Class C units with no economic impact","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: governance_change","same SEC item: 3.03, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-053558","json":"https://secwatch.observer/filing/0001104659-26-053558.json","markdown":"https://secwatch.observer/filing/0001104659-26-053558.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637757/000110465926053558/0001104659-26-053558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637757/000110465926053558/tm2613250d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"On March 5, 2026, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-three (1-for-3) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000395/0001640334-26-000395-index.htm","comparable_excerpt":"In connection with the Class A Stock Conversion, on May 1, 2026, Clearway, Inc. and Clearway Energy Group LLC amended and restated the Fourth Amended and Restated Limited Liability Company Agreement of the Company by entering into a Fifth Amended and Restated Limited Liability Company Agreement of the Company (the “Fifth Amended Company Agreement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1637757/000110465926053558/0001104659-26-053558-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}